Suite 60W
221 West Philadelphia Street
York, Pennsylvania 28277-3607
Phone: 18445463722
www.dentsplysirona.com
Dentsply Sirona appoints Gregory Lucier as chairman of the board, while Eric Brandt transitions from his role and Harry Jansen Kraemer Jr.
CHARLOTTE, N.C., Sept. 29, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that, as part of its planned succession process and con…
… Exchange Commission. The institutional investor purchased 3,018 shares … funds and other institutional investors have also modified … currently owned by institutional investors . DENTSPLY SIRONA Trading … 87. Want More Great Investing Ideas? DENTSPLY SIRONA (NASDAQ …
DENTSPLY SIRONA''s latest numbers reinforce a hold thesis based on underlying economics and value drivers, in my view. Click here for more on XRAY stock.
Chicago, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The Medical Composites Market size is expected to reach USD 1,478 million by 2025, projecting a CAGR of 9.9% between 2020 and 2025, as per the recent study by MarketsandMarkets™ . Applications of medical composites are increasing in diagnostic imaging, composite body implants, surgical instruments, and dental applications due to their exceptional properties. The increasing demand for medical composites from diagnostic imaging applications drives the medical composites market Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=181559256 Browse in-depth TOC on "Medical Composites Market " 126 - Market Data Tables 32 - Figures 163 - Pages List of Key Players in Medical Composites Market : 3M (US), Toray Industries, Inc. (Japan) CeramTec GmbH (Germany) Dentsply Sirona (US) Royal DSM N.V. (Netherlands) SGL Carbon (Germany) Isotek AG (Switzerland) Key Findings of the Study: Carbon fiber type of medical composites comprises a major share of the medical composites market in terms of value and volume.
DENTSPLY SIRONA, Inc. (NASDAQ:NASDAQ:XRAY) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ETCompany ParticipantsAndrea Daley - Vice President, Investor RelationsSimon Campion -…
Dentsply Sirona Inc (NASDAQ: XRAY ) reported Q2 adjusted EPS of $0.51, down 26% from $0.69 a year ago, beating the consensus of $0.43 . Sales of $1.03 billion increased 05% Y/Y (organic sales increased 2.3%), beating the consensus of $992.15 million . "We are pleased with our second quarter results, the highlight of which was organic growth in all four segments. Notably, aligners delivered another quarter of double-digit growth, and our business in China returned to growth," said President and Chief Executive Officer Simon Campion. Guidance: Dentsply Sirona estimates adjusted EPS of $1.91-$2.02, up … Full story available on Benzinga.com
The following slide deck was published by DENTSPLY SIRONA Inc.
YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc (XRAY) reported earnings for its second quarter that increased from the same period last year and beat the Street estimates.The company''s bottom…
Dentsply Sirona press release (XRAY): Q2 Non-GAAP EPS of $0.51 beats by $0.08.Revenue of $1.03B (+1.0% Y/Y) beats by $30.87M.Adjusted EBITDA margin of 17.7%, adjusted EPS…